Purpose
The Industry Liaison Committee (ILC) is established to:
- Foster ethical, transparent, and mutually beneficial partnerships between the Canadian Society of Nephrology (CSN) and a broad range of corporate stakeholders, including but not limited to the pharmaceutical and medical device industries, insurers, financial institutions, and other organizations that align with CSN’s mission and objectives.
- Promote collaboration that advances nephrology research, education, and patient care in Canada.
- Ensure that all interactions with industry align with the CSN’s mission, values, and ethical guidelines.
All industry engagements are structured to ensure compliance with CSN’s ethical guidelines, and they do not imply endorsement or sponsorship of any specific company, product, or service.
To reach the Industry Liaison Committee, please send an email to: industryliaison@csnscn.ca
Objectives
The primary objectives of the ILC are to:
1. Facilitate Partnerships: Develop and maintain strategic alliances with industry stakeholders to support CSN’s initiatives in research, education, and clinical practice.
2. Uphold the highest ethical standards in all interactions with industry, ensuring transparency, independence, and avoidance of conflicts of interest.
3. Additional objectives, in collaboration with the other CSN committees, will be to:
- Promote Innovation: Encourage the development and adoption of innovative therapies, technologies, and practices in nephrology.
- Support Education: Facilitate collaboration with industry to enhance educational programs for CSN members, including continuing medical education (CME) and professional development. Facilitate industry-sponsored research opportunities that align with CSN’s priorities and benefit Canadians with or at risk for kidney disease.
Key Activities
Key Activities of the ILC will be to:
1. Identify Opportunities: Identify and evaluate potential partnerships, sponsorships, and collaborations with industry, including solicitation of potential new partners in industry.
2. Develop/adopt ethical engagement Guidelines: Create and maintain guidelines for ethical engagement with industry partners.
3. Meet regularly with industry partners (min. twice a year and as needed) on behalf of the CSN.
4. Monitor Compliance: Ensure all industry interactions comply with CSN policies, Canadian healthcare regulations, and ethical standards.
5. Report to the CSN Board: Provide regular updates and recommendations to the CSN Board of Directors.
Committee Members

Veronica
Silva
Chair, Industry Liaison Committee

Manish
Sood
Vice-Chair, Industry Liaison Committee

Arti
Dhoot

Ingi
El-Sayed

Vincent
Ki

Shaifali
Sandal


